Ticker ARNA – Arena Pharma – sales, description, marketcap – Tickerday.com

ARNA

Arena Pharma

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 4.36B; Volume: 90.14K; AvgVol 3m: 522.64K; Beta: ;

Cost estimate:

P/E: ; EPS: -6.83; EPS growth quarter/prev quarter: -30.10%;

EPS growth this year: -197.50%; EPS growth past 5 years: 36.80%;

EPS ttm: -6.83;

P/S: 976.45; P/B: 3.28; P/Cashflow: 3.84; P/FCF: ;

Sales: 4.61M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: 85.20%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -28.60%; ROE – return on equity: -31.10%; LT Debt/Equity: 0.04; Total Debt/Equity: 0.04;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 0.10%; Insider Transactions:-86.46%;

Institutional Ownership: 94.00%; Institutional Transactions: 19.06%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *